Systematic review Experimental dermatology · 2026 The Emerging Role of Gut Microbiota in Inflammatory Skin Diseases: A Systematic Review. Malgesini A, Marsiglia MD, Borghi E, et al. Akkermansia muciniphilaFaecalibacterium prausnitziiMediterraneibacter gnavus PubMed ↗
Observational Actas dermo-sifiliograficas · 2025 Relation Between Gut Microbiome and Inflammatory Interleukins in Psoriasis Patients Compared to Healthy Controls: An Observational Study. Schneller-Pavelescu L, Mora-Martínez C, Sánchez-Pujol MJ, et al. Phocaeicola plebeius PubMed ↗
Review Inflammopharmacology · 2025 Unravelling the gut-skin axis: the role of gut microbiota in pathogenesis and management of psoriasis. Pachauri A, Sharma S Faecalibacterium prausnitziiSegatella copri PubMed ↗
Observational Microbiology spectrum · 2024 Eubacterium rectale is a potential marker of altered gut microbiota in psoriasis and psoriatic arthritis. Xiao Y, Wang Y, Tong B, et al. Agathobacter rectalis PubMed ↗
Observational Letters in applied microbiology · 2021 The gut microbiota profile in psoriasis: a Brazilian case-control study. Schade L, Mesa D, Faria AR, et al. Akkermansia muciniphilaSegatella copri PubMed ↗
Clinical trial Sheng wu gong cheng xue bao = Chinese journal of biotechnology · 2021 [Treatment of psoriasis vulgaris using Bacteroides fragilis BF839: a single-arm, open preliminary clinical study]. Lin C, Zeng T, Deng Y, et al. Bacteroides fragilis PubMed ↗
Review International journal of molecular sciences · 2021 Alterations of the Skin and Gut Microbiome in Psoriasis and Psoriatic Arthritis. Olejniczak-Staruch I, Ciążyńska M, Sobolewska-Sztychny D, et al. Escherichia coli PubMed ↗
Gut microbes · 2026 Gut-derived genistein from Parabacteroides distasonis alleviates psoriatic inflammation via CD200-mediated NF-κB inhibition in mice. Le D, Heidari MH, Zhu S, et al. Parabacteroides distasonis PubMed ↗
International journal of molecular sciences · 2025 Microbial Biotransformation of Chicory by Bacteroides fragilis: In Vitro Implications for Obesity-Related Psoriasis. Chervet A, Nehme R, Defois-Fraysse C, et al. Bacteroides fragilis PubMed ↗
International immunopharmacology · 2025 Gut microbiota-derived histamine exacerbates psoriasis by promoting γδT17 cell differentiation via the Hrh1/Wnt Axis. Cheng W, He M, Jurat E, et al. Escherichia coli PubMed ↗
International journal of molecular sciences · 2025 Microbial Signatures of Obesity-Aggravated Psoriasis: Insights from an Imiquimod-Based Mouse Model. Constantin C, Dobre EG, Istvan P, et al. Alistipes putredinisAnaerostipes hadrus PubMed ↗
Archives of dermatological research · 2025 CD8 + T cells may mediate the effect of gut microbiota on psoriasis: evidence from two-step mendelian randomization and bayesian weighting. Li X, Wu Y, Chen S, et al. Escherichia coli PubMed ↗
International immunopharmacology · 2025 Modulation of gut propionate and intestinal mucosal protection by Bifidobacterium longum: Mitigating methotrexate side effects without compromising the efficacy of psoriasis therapy. Mao M, Yuan Y, Li R, et al. Bifidobacterium longum PubMed ↗
The Australasian journal of dermatology · 2024 Investigating causal relationships between the gut microbiota and inflammatory skin diseases: A Mendelian randomization study. Gu Y, Zhang W, Zhao W, et al. Faecalicatena fissicatena PubMed ↗
Journal of cellular and molecular medicine · 2023 Psoriasis and gut microbiota: A Mendelian randomization study. Wu R, Zhao L, Wu Z, et al. Faecalicatena fissicatena PubMed ↗
International journal of molecular sciences · 2023 A Novel E3 Probiotics Formula Restored Gut Dysbiosis and Remodelled Gut Microbial Network and Microbiome Dysbiosis Index (MDI) in Southern Chinese Adult Psoriasis Patients. Choy CT, Chan UK, Siu PLK, et al. Blautia wexleraeParabacteroides distasonis PubMed ↗
Microbial pathogenesis · 2023 Altered gut microbiome composition in nontreated plaque psoriasis patients. Wen C, Pan Y, Gao M, et al. Escherichia coli PubMed ↗
Probiotics and antimicrobial proteins · 2022 Improvement of Psoriasis Using Oral Probiotic Streptococcus salivarius K-12: a Case-Control 24-Month Longitudinal Study. Zangrilli A, Diluvio L, Di Stadio A, et al. Streptococcus salivarius PubMed ↗
Animal study The Journal of investigative dermatology · 2025 Metformin Treatment Protects Mice from Glucose-Promoted Psoriasiform Dermatitis through Enrichment of Akkermansia muciniphila with Modulation of Bacterial Tryptophan Metabolites. Lai Y, Jiang Z, Qiu X, et al. Akkermansia muciniphila PubMed ↗
Animal study International journal of biological macromolecules · 2024 Development of interleukin-27 recombinant Lactococcus lactis and its efficacy in treating psoriasis and colitis in mice. Qian S, Zhang X, Zheng X, et al. Lactococcus lactis PubMed ↗
Animal study Cell reports · 2023 High-fat-diet-associated intestinal microbiota exacerbates psoriasis-like inflammation by enhancing systemic γδ T cell IL-17 production. Sonomoto K, Song R, Eriksson D, et al. Akkermansia muciniphila PubMed ↗
Animal study Nutrients · 2023 Dose-Response Efficacy and Mechanisms of Orally Administered Bifidobacterium breve CCFM683 on IMQ-Induced Psoriasis in Mice. Chen X, Chen Y, Stanton C, et al. Bifidobacterium breve PubMed ↗
Animal study Signal transduction and targeted therapy · 2023 Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism. Zhao Q, Yu J, Zhou H, et al. Parabacteroides distasonis PubMed ↗
Observational The Journal of dermatology · 2019 Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls. Shapiro J, Cohen NA, Shalev V, et al. Collinsella aerofaciensDorea formicigeneransParabacteroides distasonisSegatella copri PubMed ↗
Experimental dermatology · 2018 The Akkermansia muciniphila is a gut microbiota signature in psoriasis. Tan L, Zhao S, Zhu W, et al. Akkermansia muciniphila PubMed ↗